REVB FY 2024 Earnings — Revelation Biosciences, Inc. Revenue & Financial Results | Market Cap Arena

REVBRevelation Biosciences, Inc.

$2M

FY 2024 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

-$27,923

Operating Income

-$8M

Net Income

-$15M

EPS (Diluted)

$-87.68

Cash Flow

Operating Cash Flow

-$18M

Free Cash Flow

-$18M

Stock-Based Comp.

$168,850

Balance Sheet

Total Assets

$7M

Total Liabilities

$2M

Stockholders' Equity

$5M

Cash & Equivalents

$6M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	-$27,923	-$25,049	-11.5%
Operating Income	-$8M	-$9M	+7.9%
Net Income	-$15M	-$120,254	-12405.6%